Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.21M Sell
9,402
-692
-7% -$81K 0.17% 71
2026
Q1
$1.21M Buy
10,094
+1,977
+24% +$228K 0.18% 66
2025
Q4
$854K Buy
8,117
+2,124
+35% +$199K 0.13% 93
2025
Q3
$503K Sell
5,993
-4,323
-42% -$356K 0.09% 148
2025
Q2
$817K Buy
10,316
+3,865
+60% +$307K 0.16% 83
2025
Q1
$579K Sell
6,451
-1,900
-23% -$177K 0.1% 105
2024
Q4
$831K Sell
8,351
-12
-0.1% -$1.24K 0.18% 74
2024
Q3
$950K Sell
8,363
-89
-1% -$10.6K 0.22% 66
2024
Q2
$1.05M Sell
8,452
-182
-2% -$23.4K 0.27% 50
2024
Q1
$1.14M Buy
8,634
+61
+0.7% +$7.52K 0.31% 50
2023
Q4
$935K Sell
8,573
-894
-9% -$92.8K 0.28% 56
2023
Q3
$975K Buy
9,467
+404
+4% +$43.5K 0.32% 52
2023
Q2
$1.05M Buy
9,063
+249
+3% +$28.3K 0.35% 50
2023
Q1
$938K Sell
8,814
-186
-2% -$20.1K 0.33% 52
2022
Q4
$999K Buy
9,000
+659
+8% +$67.4K 0.41% 41
2022
Q3
$718K Buy
8,341
+4,669
+127% +$417K 0.32% 53
2022
Q2
$334K Buy
3,672
+762
+26% +$67.6K 0.14% 96
2022
Q1
$240K Buy
+2,910
New +$229K 0.08% 126
2021
Q1
Sell
-3,136
Closed -$245K 144
2020
Q4
$245K Sell
3,136
-3,551
-53% -$272K 0.08% 116
2020
Q3
$530K Buy
6,687
+3,064
+85% +$240K 0.16% 91
2020
Q2
$268K Buy
+3,623
New +$273K 0.11% 99

Other funds holding MRK

Optas LLC's MRK Position: Q2 2026 in Review

Optas LLC reduced its Merck (MRK) stake by 6.9% in Q2 2026, selling an estimated $81K and leaving 9,402 shares worth $1.21M. The position accounts for 0.17% of the portfolio, ranked #71.

Optas LLC first reported a position in MRK in Q2 2020 and has held it in 21 quarters since. The position peaked at $1.21M in Q1 2026. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Optas LLC held 9,402 shares of Merck worth $1.21M as of Q2 2026.
  • Optas LLC sold 692 Merck shares in Q2 2026, an estimated $81K.
  • Merck made up 0.17% of Optas LLC's portfolio in Q2 2026, its #71 holding.
  • Optas LLC first reported a position in Merck in Q2 2020 and has held it in 21 quarters since.
  • Optas LLC's Merck position peaked at $1.21M in Q1 2026.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Optas LLC's 13F filing for Q2 2026, filed 21 Jul 2026.